Chronic obstructive pulmonary disease and cardiovascular mortality in elderly subjects from general population
Abstract Aims. To ascertain whether chronic obstructive pulmonary disease (COPD) is an independent risk factor for cardiovascular (CV) mortality in the elderly subjects from general population. Methods. 3282 subjects of the Northern Italy aged ≥65 years were followed up for 12 years in the frame of...
Gespeichert in:
Veröffentlicht in: | Blood pressure 2010, Vol.19 (2), p.67-74 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 74 |
---|---|
container_issue | 2 |
container_start_page | 67 |
container_title | Blood pressure |
container_volume | 19 |
creator | Mazza, Alberto Zamboni, Sergio Rubello, Domenico Schiavon, Laura Zorzan, Sara Casiglia, Edoardo |
description | Abstract
Aims. To ascertain whether chronic obstructive pulmonary disease (COPD) is an independent risk factor for cardiovascular (CV) mortality in the elderly subjects from general population. Methods. 3282 subjects of the Northern Italy aged ≥65 years were followed up for 12 years in the frame of the CArdiovascular STtudy in the ELderly. Multivariate stepwise proportional hazard Cox regression was therefore used to identify the prognostic role of COPD on CV mortality in hypertensive (HT) and normotensive (NT) subjects. The hazard ratio (HR) of COPD with 95% confidence interval (CI) for mortality was adjusted for confounders in both genders. Results. COPD resulted to be an independent predictor of CV mortality (HR 1.34, CI 1.13-1.61) in HT but not in NT subjects. This was evident both in men (HR 1.44, 1.25-1.95) and women (HR 1.32, CI 1.14-1.53); pulse pressure (PP) was directly related and anti-hypertensive therapy inversely related to risk of CV mortality, an association that was greater in subjects with than without COPD. Conclusion. COPD should be included in the computation of global risk in HT subjects. PP is the main BP component in increasing CV risk in subjects with COPD. Controlled trials should be performed to evaluate the pressor targets to be reached in HT subjects with COPD, with the aim of decreasing their CV risk. |
doi_str_mv | 10.3109/08037050903464642 |
format | Article |
fullrecord | <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_proquest_miscellaneous_733855896</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733855896</sourcerecordid><originalsourceid>FETCH-LOGICAL-c514t-9f720c6939b678cfb37d15ffd4f25d068b2bffa5ea95d1db3a4145ab5dbfe0423</originalsourceid><addsrcrecordid>eNp9kM2KFDEUhYM4OO3oA7iR7FyVJpVKVQXdSOMfDMxmZl3c_NlpUkl7k5qh395qehRElCxu4H7nIzmEvOLsreBMvWMjEwOTTDHR9etpn5AN7yVvuFLqKdmc9s0K8EvyvJQ9Y1wIxp6Ry5ad7kpsSNruMKdgaNal4mJquHf0sMQ5J8AjtaE4KI5CstQA2pDvoZglAtI5Y4UY6pGGRF20DuORlkXvnamFeswz_e6SQ4j0kFcj1JDTC3LhIRb38nFekbvPn263X5vrmy_fth-vGyN5Vxvlh5aZXgml-2E0XovBcum97XwrLetH3WrvQTpQ0nKrBXS8k6Cl1d6xrhVX5M3Ze8D8Y3GlTnMoxsUIyeWlTIMQo5Sj6leSn0mDuRR0fjpgmNe_T5xNp5anv1peM68f7Yuenf2d-FXrCnw4AyH5jDM8ZIx2qnCMGT1CMqGc3P_2v_8jvnMQ627t3037vGBam_vP634CP0qgUw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733855896</pqid></control><display><type>article</type><title>Chronic obstructive pulmonary disease and cardiovascular mortality in elderly subjects from general population</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Mazza, Alberto ; Zamboni, Sergio ; Rubello, Domenico ; Schiavon, Laura ; Zorzan, Sara ; Casiglia, Edoardo</creator><creatorcontrib>Mazza, Alberto ; Zamboni, Sergio ; Rubello, Domenico ; Schiavon, Laura ; Zorzan, Sara ; Casiglia, Edoardo</creatorcontrib><description>Abstract
Aims. To ascertain whether chronic obstructive pulmonary disease (COPD) is an independent risk factor for cardiovascular (CV) mortality in the elderly subjects from general population. Methods. 3282 subjects of the Northern Italy aged ≥65 years were followed up for 12 years in the frame of the CArdiovascular STtudy in the ELderly. Multivariate stepwise proportional hazard Cox regression was therefore used to identify the prognostic role of COPD on CV mortality in hypertensive (HT) and normotensive (NT) subjects. The hazard ratio (HR) of COPD with 95% confidence interval (CI) for mortality was adjusted for confounders in both genders. Results. COPD resulted to be an independent predictor of CV mortality (HR 1.34, CI 1.13-1.61) in HT but not in NT subjects. This was evident both in men (HR 1.44, 1.25-1.95) and women (HR 1.32, CI 1.14-1.53); pulse pressure (PP) was directly related and anti-hypertensive therapy inversely related to risk of CV mortality, an association that was greater in subjects with than without COPD. Conclusion. COPD should be included in the computation of global risk in HT subjects. PP is the main BP component in increasing CV risk in subjects with COPD. Controlled trials should be performed to evaluate the pressor targets to be reached in HT subjects with COPD, with the aim of decreasing their CV risk.</description><identifier>ISSN: 0803-7051</identifier><identifier>EISSN: 1651-1999</identifier><identifier>DOI: 10.3109/08037050903464642</identifier><identifier>PMID: 20001393</identifier><language>eng</language><publisher>England: Informa UK Ltd. (Informa Healthcare, Taylor & Francis AS)</publisher><subject>Aged ; Antihypertensive Agents - therapeutic use ; Arterial hypertension ; Cardiovascular Diseases - drug therapy ; Cardiovascular Diseases - mortality ; chronic obstructive pulmonary disease ; elderly ; Female ; Humans ; Hypertension - drug therapy ; Hypertension - mortality ; Hypertension - physiopathology ; Male ; mortality ; Prognosis ; Pulmonary Disease, Chronic Obstructive - drug therapy ; Pulmonary Disease, Chronic Obstructive - mortality ; Risk Factors</subject><ispartof>Blood pressure, 2010, Vol.19 (2), p.67-74</ispartof><rights>Informa UK Ltd 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c514t-9f720c6939b678cfb37d15ffd4f25d068b2bffa5ea95d1db3a4145ab5dbfe0423</citedby><cites>FETCH-LOGICAL-c514t-9f720c6939b678cfb37d15ffd4f25d068b2bffa5ea95d1db3a4145ab5dbfe0423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4009,27902,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20001393$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mazza, Alberto</creatorcontrib><creatorcontrib>Zamboni, Sergio</creatorcontrib><creatorcontrib>Rubello, Domenico</creatorcontrib><creatorcontrib>Schiavon, Laura</creatorcontrib><creatorcontrib>Zorzan, Sara</creatorcontrib><creatorcontrib>Casiglia, Edoardo</creatorcontrib><title>Chronic obstructive pulmonary disease and cardiovascular mortality in elderly subjects from general population</title><title>Blood pressure</title><addtitle>Blood Press</addtitle><description>Abstract
Aims. To ascertain whether chronic obstructive pulmonary disease (COPD) is an independent risk factor for cardiovascular (CV) mortality in the elderly subjects from general population. Methods. 3282 subjects of the Northern Italy aged ≥65 years were followed up for 12 years in the frame of the CArdiovascular STtudy in the ELderly. Multivariate stepwise proportional hazard Cox regression was therefore used to identify the prognostic role of COPD on CV mortality in hypertensive (HT) and normotensive (NT) subjects. The hazard ratio (HR) of COPD with 95% confidence interval (CI) for mortality was adjusted for confounders in both genders. Results. COPD resulted to be an independent predictor of CV mortality (HR 1.34, CI 1.13-1.61) in HT but not in NT subjects. This was evident both in men (HR 1.44, 1.25-1.95) and women (HR 1.32, CI 1.14-1.53); pulse pressure (PP) was directly related and anti-hypertensive therapy inversely related to risk of CV mortality, an association that was greater in subjects with than without COPD. Conclusion. COPD should be included in the computation of global risk in HT subjects. PP is the main BP component in increasing CV risk in subjects with COPD. Controlled trials should be performed to evaluate the pressor targets to be reached in HT subjects with COPD, with the aim of decreasing their CV risk.</description><subject>Aged</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Arterial hypertension</subject><subject>Cardiovascular Diseases - drug therapy</subject><subject>Cardiovascular Diseases - mortality</subject><subject>chronic obstructive pulmonary disease</subject><subject>elderly</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - mortality</subject><subject>Hypertension - physiopathology</subject><subject>Male</subject><subject>mortality</subject><subject>Prognosis</subject><subject>Pulmonary Disease, Chronic Obstructive - drug therapy</subject><subject>Pulmonary Disease, Chronic Obstructive - mortality</subject><subject>Risk Factors</subject><issn>0803-7051</issn><issn>1651-1999</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM2KFDEUhYM4OO3oA7iR7FyVJpVKVQXdSOMfDMxmZl3c_NlpUkl7k5qh395qehRElCxu4H7nIzmEvOLsreBMvWMjEwOTTDHR9etpn5AN7yVvuFLqKdmc9s0K8EvyvJQ9Y1wIxp6Ry5ad7kpsSNruMKdgaNal4mJquHf0sMQ5J8AjtaE4KI5CstQA2pDvoZglAtI5Y4UY6pGGRF20DuORlkXvnamFeswz_e6SQ4j0kFcj1JDTC3LhIRb38nFekbvPn263X5vrmy_fth-vGyN5Vxvlh5aZXgml-2E0XovBcum97XwrLetH3WrvQTpQ0nKrBXS8k6Cl1d6xrhVX5M3Ze8D8Y3GlTnMoxsUIyeWlTIMQo5Sj6leSn0mDuRR0fjpgmNe_T5xNp5anv1peM68f7Yuenf2d-FXrCnw4AyH5jDM8ZIx2qnCMGT1CMqGc3P_2v_8jvnMQ627t3037vGBam_vP634CP0qgUw</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>Mazza, Alberto</creator><creator>Zamboni, Sergio</creator><creator>Rubello, Domenico</creator><creator>Schiavon, Laura</creator><creator>Zorzan, Sara</creator><creator>Casiglia, Edoardo</creator><general>Informa UK Ltd. (Informa Healthcare, Taylor & Francis AS)</general><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2010</creationdate><title>Chronic obstructive pulmonary disease and cardiovascular mortality in elderly subjects from general population</title><author>Mazza, Alberto ; Zamboni, Sergio ; Rubello, Domenico ; Schiavon, Laura ; Zorzan, Sara ; Casiglia, Edoardo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c514t-9f720c6939b678cfb37d15ffd4f25d068b2bffa5ea95d1db3a4145ab5dbfe0423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Aged</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Arterial hypertension</topic><topic>Cardiovascular Diseases - drug therapy</topic><topic>Cardiovascular Diseases - mortality</topic><topic>chronic obstructive pulmonary disease</topic><topic>elderly</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - mortality</topic><topic>Hypertension - physiopathology</topic><topic>Male</topic><topic>mortality</topic><topic>Prognosis</topic><topic>Pulmonary Disease, Chronic Obstructive - drug therapy</topic><topic>Pulmonary Disease, Chronic Obstructive - mortality</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mazza, Alberto</creatorcontrib><creatorcontrib>Zamboni, Sergio</creatorcontrib><creatorcontrib>Rubello, Domenico</creatorcontrib><creatorcontrib>Schiavon, Laura</creatorcontrib><creatorcontrib>Zorzan, Sara</creatorcontrib><creatorcontrib>Casiglia, Edoardo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood pressure</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mazza, Alberto</au><au>Zamboni, Sergio</au><au>Rubello, Domenico</au><au>Schiavon, Laura</au><au>Zorzan, Sara</au><au>Casiglia, Edoardo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic obstructive pulmonary disease and cardiovascular mortality in elderly subjects from general population</atitle><jtitle>Blood pressure</jtitle><addtitle>Blood Press</addtitle><date>2010</date><risdate>2010</risdate><volume>19</volume><issue>2</issue><spage>67</spage><epage>74</epage><pages>67-74</pages><issn>0803-7051</issn><eissn>1651-1999</eissn><abstract>Abstract
Aims. To ascertain whether chronic obstructive pulmonary disease (COPD) is an independent risk factor for cardiovascular (CV) mortality in the elderly subjects from general population. Methods. 3282 subjects of the Northern Italy aged ≥65 years were followed up for 12 years in the frame of the CArdiovascular STtudy in the ELderly. Multivariate stepwise proportional hazard Cox regression was therefore used to identify the prognostic role of COPD on CV mortality in hypertensive (HT) and normotensive (NT) subjects. The hazard ratio (HR) of COPD with 95% confidence interval (CI) for mortality was adjusted for confounders in both genders. Results. COPD resulted to be an independent predictor of CV mortality (HR 1.34, CI 1.13-1.61) in HT but not in NT subjects. This was evident both in men (HR 1.44, 1.25-1.95) and women (HR 1.32, CI 1.14-1.53); pulse pressure (PP) was directly related and anti-hypertensive therapy inversely related to risk of CV mortality, an association that was greater in subjects with than without COPD. Conclusion. COPD should be included in the computation of global risk in HT subjects. PP is the main BP component in increasing CV risk in subjects with COPD. Controlled trials should be performed to evaluate the pressor targets to be reached in HT subjects with COPD, with the aim of decreasing their CV risk.</abstract><cop>England</cop><pub>Informa UK Ltd. (Informa Healthcare, Taylor & Francis AS)</pub><pmid>20001393</pmid><doi>10.3109/08037050903464642</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0803-7051 |
ispartof | Blood pressure, 2010, Vol.19 (2), p.67-74 |
issn | 0803-7051 1651-1999 |
language | eng |
recordid | cdi_proquest_miscellaneous_733855896 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
subjects | Aged Antihypertensive Agents - therapeutic use Arterial hypertension Cardiovascular Diseases - drug therapy Cardiovascular Diseases - mortality chronic obstructive pulmonary disease elderly Female Humans Hypertension - drug therapy Hypertension - mortality Hypertension - physiopathology Male mortality Prognosis Pulmonary Disease, Chronic Obstructive - drug therapy Pulmonary Disease, Chronic Obstructive - mortality Risk Factors |
title | Chronic obstructive pulmonary disease and cardiovascular mortality in elderly subjects from general population |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T06%3A14%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20obstructive%20pulmonary%20disease%20and%20cardiovascular%20mortality%20in%20elderly%20subjects%20from%20general%20population&rft.jtitle=Blood%20pressure&rft.au=Mazza,%20Alberto&rft.date=2010&rft.volume=19&rft.issue=2&rft.spage=67&rft.epage=74&rft.pages=67-74&rft.issn=0803-7051&rft.eissn=1651-1999&rft_id=info:doi/10.3109/08037050903464642&rft_dat=%3Cproquest_infor%3E733855896%3C/proquest_infor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733855896&rft_id=info:pmid/20001393&rfr_iscdi=true |